Top what type of drug is nembutal Secrets
Top what type of drug is nembutal Secrets
Blog Article
pentobarbital will reduce the extent or result of voriconazole by affecting hepatic enzyme CYP2C9/10 metabolism. Small/Importance Unknown.
Barbiturates can induce hepatic microsomal enzymes causing elevated metabolism and decreased anticoagulant reaction of oral anticoagulants (eg, warfarin, acenocoumarol, dicumarol, and phenprocoumon); patients stabilized on anticoagulant therapy may involve dosage changes if barbiturates are additional to or withdrawn from their dosage regimen
pentobarbital will lessen the extent or effect of paclitaxel by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Unidentified.
pentobarbital will decrease the level or influence of etravirine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
fentanyl transmucosal and pentobarbital both boost sedation. Keep away from or Use Alternate Drug. Restrict use to clients for whom alternate therapy choices are insufficient
Watch Closely (1)pentobarbital will decrease the extent or outcome of glecaprevir/pibrentasvir by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lessen the level or influence of fentanyl transmucosal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Carefully. Coadministration of fentanyl with CYP3A4 inducers may lead to your minimize in fentanyl plasma concentrations, insufficient efficacy or, quite possibly, development of a withdrawal syndrome within a more info patient who may have produced Bodily dependence to fentanyl.
pentobarbital will minimize the extent or influence of almotriptan by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
pentobarbital will increase toxicity of methoxyflurane by rising metabolism. Contraindicated. Enhanced metabolism of methoxyflurane to nephrotoxic compounds.
Monitor Carefully (two)pentobarbital will reduce the extent or effect of oliceridine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. If coadministration having a CYP3A4 inducer is critical, consider raising oliceridine dose until eventually secure drug effects are attained; keep an eye on for signs of opioid withdrawal.
pentobarbital will reduce the extent or influence of pioglitazone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
pentobarbital will minimize the extent or impact of parecoxib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unidentified.
pentobarbital will decrease the level or result of tolterodine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
Contraindicated (one)pentobarbital will lessen the level or outcome of cobimetinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Stay away from coadministration. Strong or average CYP3A inducers could decrease cobimetinib systemic publicity by >80% and lessen its efficacy.